HPV vaccination not cost-effective in women aged older than 30

DiMarcantonio, Tina; Haigh, Christen; Harris, Jason; Lawrence, Leah
November 2009
Hem/Onc Today;11/10/2009, Vol. 10 Issue 21, p22
The article discusses a study by JJ. Kim and colleagues about human papillomavirus (HPV) vaccination for women aged older than 30 published in the "Annals of Internal Medicine."


Related Articles

  • Comparing the HPV vaccines. Blamble, Deborah // Hem/Onc Today;3/25/2010, Vol. 11 Issue 6, p6 

    The article discusses various studies on human papillomavirus (HPV) vaccines, including quadrivalent and bivalent vaccines.

  • Value of cervical cancer vax in France?  // PharmacoEconomics & Outcomes News;4/2/2011, Issue 625, p5 

    The article discusses research on the value of human papillomavirus (HPV) vaccine in France, by J. P. Fagot and colleagues, published in "Vaccine."

  • HPV vaccine protected against low-grade lesions for more than 3 years. Cona, Christen; Harris, Jason; Southall, Jennifer // Hem/Onc Today;9/10/2010, Vol. 11 Issue 17, p44 

    The article discusses research on the effectiveness of quadrivalent human papillomavirus (HPV) vaccine in preventing HPV types 6, 11, 16 and 18, by J. Dillner and colleagues, published in the 2010 issue of "British Medical Journal."

  • HPV vaccine showing some protective effects for unvaccinated.  // Infectious Diseases in Children;Aug2012, Vol. 25 Issue 8, p22 

    The article offers information on a study that highlighted the effectivity of routine use of human papillomavirus vaccines in decreasing disease-incidence of vaccine serotypes.

  • Rates of two HPV-related cancers increased, HPV vaccination low. Shafer, Emily // Infectious Disease News;Feb2013, Vol. 26 Issue 2, p22 

    The article discusses research being done on the rates of cancers related to human papillomavirus (HPV) and HPV vaccination. It references a study by A. Jemal which was published in the 2013 issue of the "Journal of National Cancer Institute." The study found out that the incidence rates for two...

  • Parental report increases HPV vaccine uptake.  // PharmacoEconomics & Outcomes News;3/31/2012, Issue 650, p8 

    The article reports on a study which found an association between parental report of a healthcare provider recommendation with initiation of a human papillomavirus (HPV) vaccine series in adolescent females aged 12-17 years.

  • Peer health advisors increased awareness of HPV vaccine. Cox, Amber // Infectious Diseases in Children;Apr2013, Vol. 26 Issue 4, p12 

    The article discusses a research study which revealed that Teen Community Health Advisors were a key component in informing adolescents about human papilloma virus (HPV) vaccine, presented at the Society of Adolescent Health and Medicine Meeting in Atlanta, Georgia on March 13-16, 2013.

  • Most docs don't give HPV shot to males.  // Journal of Business (10756124);10/9/2014, Vol. 29 Issue 21, pA13 

    The article offers information on a research conducted by the U.S.-based Moffitt Cancer Center as of October 2014 which revelas that family physicians and pediatricians in the country do not always recommend vaccination against human papillomavirus (HPV) for young male patients.

  • Full effects of HPV vaccination not seen for many years.  // Nursing Standard;4/21/2010, Vol. 24 Issue 33, p16 

    The article discusses research which found that the full benefits of the human papillomavirus (HPV) vaccine may not become apparent in populations for at least ten years.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics